New Key Statistics Module, Z-Score and F-Score
NAS:ALLO Key Ratios
Market Cap $ M | 519.87 |
Enterprise Value $ M | 217.67 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.91 |
Price/Sales | 2,460.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -1.82 |
Beneish M-Score | -3.53 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 17.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.76 |
EV-to-EBITDA | -0.80 |
PEG | -- |
Shares Outstanding M | 208.78 |
Net Margin (%) | -451,632.31 |
Operating Margin % | -438,347.69 |
Pre-tax Margin (%) | -451,632.31 |
Quick Ratio | 12.80 |
Current Ratio | 12.80 |
ROA % (ttm) | -42.43 |
ROE % (ttm) | -52.95 |
ROIC % (ttm) | -121.31 |
Dividend Yield % | -- |
Altman Z-Score | -2.33 |
ALLO Number of Guru Trades
ALLO Volume of Guru Trades
Gurus Latest Trades with NAS:ALLO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ALLO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Allogene Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ALLO
Total 0- 1